Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Digestive Diseases

The Latest in Diagnosis and Treatment of Gastrointestinal Disorders

Vol. 35, No. 3, 2017

Issue release date: March 2017

Bile Acids in Health and Disease

24th International Bile Acid Meeting
Symposium 203, Düsseldorf, June 2016: Official Congress Report

See also ISBN 978-3-318-05921-2 for more details
Add all to MyReading List
 
153

Title Page / Table of Contents

Dig Dis 2017;35:153-156 (DOI:10.1159/000453346)
Free Access
157

Preface

Häussinger D.
Dig Dis 2017;35:157 (DOI:10.1159/000452153)
Bile Acid Signaling in Liver Regeneration and Tumor Development
158

Fibroblast Growth Factor 15/19 in Hepatocarcinogenesis

Alvarez-Sola G. · Uriarte I. · Latasa M.U. · Urtasun R. · Bárcena-Varela M. · Elizalde M. · Jiménez M. · Rodriguez-Ortigosa C.M. · Corrales F.J. · Fernández-Barrena M.G. · Berasain C. · Avila M.A.
Dig Dis 2017;35:158-165 (DOI:10.1159/000450905)
Bile Acids and the Gut Liver Axis
166

Role of the Intestinal Microbiome in Cholestatic Liver Disease

LaRusso N.F. · Tabibian J.H. · O'Hara S.P.
Dig Dis 2017;35:166-168 (DOI:10.1159/000450906)
169

Disease-Associated Changes in Bile Acid Profiles and Links to Altered Gut Microbiota

Joyce S.A. · Gahan C.G.M.
Dig Dis 2017;35:169-177 (DOI:10.1159/000450907)
178

Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease

Gonzalez F.J. · Jiang C. · Xie C. · Patterson A.D.
Dig Dis 2017;35:178-184 (DOI:10.1159/000450908)
185

Farnesoid X Receptor an Emerging Target to Combat Obesity

De Magalhaes Filho C.D. · Downes M. · Evans R.M.
Dig Dis 2017;35:185-190 (DOI:10.1159/000450909)
191

Impact of Fibroblast Growth Factors 19 and 21 in Bariatric Metabolism

Patton A. · Khan F.H. · Kohli R.
Dig Dis 2017;35:191-196 (DOI:10.1159/000450910)
Adolf Windaus Award Lecture
197

Progress in the Molecular Characterization of Hepatobiliary Transporters

Keppler D.
Dig Dis 2017;35:197-202 (DOI:10.1159/000450911)
Intrahepatic Signaling and Bile Acids as Endogenous Toxins
203

Regulation of Liver Energy Balance by the Nuclear Receptors Farnesoid X Receptor and Peroxisome Proliferator Activated Receptor α

Kim K.H. · Moore D.D.
Dig Dis 2017;35:203-209 (DOI:10.1159/000450912)
210

Bile Acids and Deregulated Cholangiocyte Autophagy in Primary Biliary Cholangitis

Sasaki M. · Nakanuma Y.
Dig Dis 2017;35:210-216 (DOI:10.1159/000450913)
217

The Emerging Role of Soluble Adenylyl Cyclase in Primary Biliary Cholangitis

Chang J.-C. · Beuers U. · Oude Elferink R.P.J.
Dig Dis 2017;35:217-223 (DOI:10.1159/000450914)
Open Access Gateway
224

Mechanisms of Tauroursodeoxycholate-Mediated Hepatoprotection

Häussinger D. · Kordes C.
Dig Dis 2017;35:224-231 (DOI:10.1159/000450915)
232

The Role of Inflammation in the Mechanisms of Bile Acid-Induced Liver Damage

Cai S.-Y. · Boyer J.L.
Dig Dis 2017;35:232-234 (DOI:10.1159/000450916)
235

Role of the G Protein-Coupled Bile Acid Receptor TGR5 in Liver Damage

Reich M. · Klindt C. · Deutschmann K. · Spomer L. · Häussinger D. · Keitel V.
Dig Dis 2017;35:235-240 (DOI:10.1159/000450917)
241

Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation

Chiang J.Y.L. · Pathak P. · Liu H. · Donepudi A. · Ferrell J. · Boehme S.
Dig Dis 2017;35:241-245 (DOI:10.1159/000450981)
246

Crosstalk between Bile Acids and Gut Microbiota and Its Impact on Farnesoid X Receptor Signalling

Wahlström A. · Kovatcheva-Datchary P. · Ståhlman M. · Bäckhed F. · Marschall H.-U.
Dig Dis 2017;35:246-250 (DOI:10.1159/000450982)
Bile Acid Transporters: Role in Health and Disease
251

Bile Acid Uptake Transporters as Targets for Therapy

Slijepcevic D. · van de Graaf S.F.J.
Dig Dis 2017;35:251-258 (DOI:10.1159/000450983)
Open Access Gateway
259

Extended Abstract: Deficiency of Sodium Taurocholate Cotransporting Polypeptide (SLC10A1): A New Inborn Error of Metabolism with an Attenuated Phenotype

Vaz F.M. · Huidekoper H.H. · Paulusma C.C.
Dig Dis 2017;35:259-260 (DOI:10.1159/000450984)
261

Roles of Ileal ASBT and OSTα-OSTβ in Regulating Bile Acid Signaling

Dawson P.A.
Dig Dis 2017;35:261-266 (DOI:10.1159/000450987)
267

Apical Sodium-Dependent Transporter Inhibitors in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis

Hegade V.S. · Jones D.E.J. · Hirschfield G.M.
Dig Dis 2017;35:267-274 (DOI:10.1159/000450988)
Bile Acid Receptors and Bile Acid Signaling as Therapeutic Targets
275

Bile Acids in Polycystic Liver Diseases: Triggers of Disease Progression and Potential Solution for Treatment

Perugorria M.J. · Labiano I. · Esparza-Baquer A. · Marzioni M. · Marin J.J.G. · Bujanda L. · Banales J.M.
Dig Dis 2017;35:275-281 (DOI:10.1159/000450989)
282

Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver Disease

Steinacher D. · Claudel T. · Trauner M.
Dig Dis 2017;35:282-287 (DOI:10.1159/000454853)
288

Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver Diseases

Halilbasic E. · Steinacher D. · Trauner M.
Dig Dis 2017;35:288-292 (DOI:10.1159/000454904)
 
293

Falk Symposium Series

Dig Dis 2017;35:293-295 (DOI:10.1159/000453347)
Free Access
296

Author Index Vol. 35, No. 3, 2017

Dig Dis 2017;35:296 (DOI:10.1159/000453348)
Free Access
297

Subject Index Vol. 35, No. 3, 2017

Dig Dis 2017;35:297 (DOI:10.1159/000453349)
Free Access